BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 24240934)

  • 21. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report.
    Dahle TG; Kaneko T; McCabe JM
    JACC Cardiovasc Interv; 2019 Apr; 12(7):662-669. PubMed ID: 30947940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
    van der Boon RM; Marcheix B; Tchetche D; Chieffo A; Van Mieghem NM; Dumonteil N; Vahdat O; Maisano F; Serruys PW; Kappetein AP; Fajadet J; Colombo A; Carrié D; van Domburg RT; de Jaegere PP
    Ann Thorac Surg; 2014 Jan; 97(1):22-8. PubMed ID: 24263012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis.
    Forrest JK; Ramlawi B; Deeb GM; Zahr F; Song HK; Kleiman NS; Chetcuti SJ; Michelena HI; Mangi AA; Skiles JA; Huang J; Popma JJ; Reardon MJ
    JAMA Cardiol; 2021 Jan; 6(1):50-57. PubMed ID: 33031491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of STS/ACC TVT-TAVR Score in Veterans Undergoing Transcatheter Aortic Valve Replacement.
    Reiff C; Gurevich S; Bertog S; Sorajja P; Kelly R; Garcia S
    J Invasive Cardiol; 2018 Dec; 30(12):447-451. PubMed ID: 30218556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study.
    Perlman GY; Blanke P; Dvir D; Pache G; Modine T; Barbanti M; Holy EW; Treede H; Ruile P; Neumann FJ; Gandolfo C; Saia F; Tamburino C; Mak G; Thompson C; Wood D; Leipsic J; Webb JG
    JACC Cardiovasc Interv; 2016 Apr; 9(8):817-824. PubMed ID: 27101906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility.
    Omer S; Kar B; Cornwell LD; Blaustein A; Levine GN; Ali N; Jneid H; Paniagua D; Atluri PV; Bechara CF; Kougias P; Ruma M; Preventza O; Bozkurt B; Carabello BA; Bakaeen FG
    JAMA Surg; 2013 Dec; 148(12):1087-93. PubMed ID: 24048246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke.
    Huded CP; Tuzcu EM; Krishnaswamy A; Mick SL; Kleiman NS; Svensson LG; Carroll J; Thourani VH; Kirtane AJ; Manandhar P; Kosinski AS; Vemulapalli S; Kapadia SR
    JAMA; 2019 Jun; 321(23):2306-2315. PubMed ID: 31211345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Young MN; Elmariah S; Kennedy KF; Inglessis I; Yeh RW
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):830-838. PubMed ID: 28326675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.
    Arnold SV; O'Brien SM; Vemulapalli S; Cohen DJ; Stebbins A; Brennan JM; Shahian DM; Grover FL; Holmes DR; Thourani VH; Peterson ED; Edwards FH;
    JACC Cardiovasc Interv; 2018 Mar; 11(6):581-589. PubMed ID: 29566805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk.
    Makkar RR; Yoon SH; Chakravarty T; Kapadia SR; Krishnaswamy A; Shah PB; Kaneko T; Skipper ER; Rinaldi M; Babaliaros V; Vemulapalli S; Trento A; Cheng W; Kodali S; Mack MJ; Leon MB; Thourani VH
    JAMA; 2021 Sep; 326(11):1034-1044. PubMed ID: 34546301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.
    Cohen MG; Singh V; Martinez CA; O'Neill BP; Alfonso CE; Martinezclark PO; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):987-93. PubMed ID: 23729031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.
    Holmes DR; Nishimura RA; Grover FL; Brindis RG; Carroll JD; Edwards FH; Peterson ED; Rumsfeld JS; Shahian DM; Thourani VH; Tuzcu EM; Vemulapalli S; Hewitt K; Michaels J; Fitzgerald S; Mack MJ;
    Ann Thorac Surg; 2016 Feb; 101(2):789-800. PubMed ID: 27175453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.
    Ribeiro HB; Webb JG; Makkar RR; Cohen MG; Kapadia SR; Kodali S; Tamburino C; Barbanti M; Chakravarty T; Jilaihawi H; Paradis JM; de Brito FS; Cánovas SJ; Cheema AN; de Jaegere PP; del Valle R; Chiam PT; Moreno R; Pradas G; Ruel M; Salgado-Fernández J; Sarmento-Leite R; Toeg HD; Velianou JL; Zajarias A; Babaliaros V; Cura F; Dager AE; Manoharan G; Lerakis S; Pichard AD; Radhakrishnan S; Perin MA; Dumont E; Larose E; Pasian SG; Nombela-Franco L; Urena M; Tuzcu EM; Leon MB; Amat-Santos IJ; Leipsic J; Rodés-Cabau J
    J Am Coll Cardiol; 2013 Oct; 62(17):1552-62. PubMed ID: 23954337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.